Chinese medical journal
Efficacy and safety of glucagon-like peptide-1 receptor agonist liraglutide in new-onset diabetes after kidney transplantation: An open-label, parallel-group, randomized controlled trial.
Huawei Cao, Qingrong Pan, Xihao Shen, Zejia Sun, Zihao Gao, Jiyue Wu, Zhen Li, Lijian Gan, Zhe Chen, Wei Wang
Published: 202510.1097/CM9.0000000000003880
No abstract available for this study.